Literature DB >> 11564820

Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha.

D Baram1, G G Vaday, P Salamon, I Drucker, R Hershkoviz, Y A Mekori.   

Abstract

Mast cells, essential effector cells in allergic inflammation, have been found to be activated in T cell-mediated inflammatory processes in accordance with their residence in close physical proximity to T cells. We have recently reported that mast cells release granule-associated mediators and TNF-alpha upon direct contact with activated T cells. This data suggested an unrecognized activation pathway, where mast cells may be activated during T cell-mediated inflammation. Herein, we show that this cell-cell contact results in the release of matrix metalloproteinase (MMP)-9 and the MMP inhibitor tissue inhibitor of metalloproteinase 1 from HMC-1 human mast cells or from mature peripheral blood-derived human mast cells. The expression and release of these mediators, as well as of beta-hexosaminidase and several cytokines, were also induced when mast cells were incubated with cell membranes isolated from activated, but not resting, T cells. Subcellular fractionation revealed that the mature form of MMP-9 cofractionated with histamine and tryptase, indicating its localization within the secretory granules. MMP-9 release was first detected at 6 h and peaked at 22 h of incubation with activated T cell membranes, while TNF-alpha release peaked after only 6 h. Anti-TNF-alpha mAb inhibited the T cell membrane-induced MMP-9 release, indicating a possible autocrine regulation of MMP release by mast cell TNF-alpha. This cascade of events, whereby mast cells are activated by T cells to release cytokines and MMP-9, which are known to be essential for leukocyte extravasation and recruitment to affected sites, points to an important immunoregulatory function of mast cells within the context of T cell-mediated inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564820     DOI: 10.4049/jimmunol.167.7.4008

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 2.  Biological implications of preformed mast cell mediators.

Authors:  Anders Lundequist; Gunnar Pejler
Journal:  Cell Mol Life Sci       Date:  2010-11-11       Impact factor: 9.261

Review 3.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

4.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

Authors:  Susumu Nakae; Hajime Suto; Maki Kakurai; Jonathon D Sedgwick; Mindy Tsai; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

5.  Characterization of ERK activation in human mast cells stimulated by contact with T cells.

Authors:  Adam Mor; Irit Shefler; Pazit Salamon; Yoel Kloog; Yoseph A Mekori
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

6.  Cognate interactions between mast cells and helper T lymphocytes.

Authors:  Salvatore Valitutti; Eric Espinosa
Journal:  Self Nonself       Date:  2010-03-17

Review 7.  Mast cell secretory granules: armed for battle.

Authors:  Sara Wernersson; Gunnar Pejler
Journal:  Nat Rev Immunol       Date:  2014-06-06       Impact factor: 53.106

Review 8.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

Review 9.  Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Authors:  Yi Wang; Guo-Ping Shi
Journal:  Trends Cardiovasc Med       Date:  2012-08-14       Impact factor: 6.677

10.  The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma.

Authors:  Hae-Seong Nam; Sook Young Lee; Seung Jun Kim; Ju Sang Kim; Soon Seog Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Jeong Sup Song; Sung Hak Park; Seok Chan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.